ARTH - Arch Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 585.09M
Enterprise Value 357.64M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)35.33
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-8.13

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-68.66%
Return on Equity (ttm)-217.27%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.09M
Net Income Avi to Common (ttm)-6.12M
Diluted EPS (ttm)-0.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.49M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)18.33
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-5.32M
Levered Free Cash Flow (ttm)-2.59M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.14
52-Week Change 3-36.36%
S&P500 52-Week Change 3-0.98%
52 Week High 30.78
52 Week Low 30.25
50-Day Moving Average 30.40
200-Day Moving Average 30.42

Share Statistics

Avg Vol (3 month) 3232.23k
Avg Vol (10 day) 3337.98k
Shares Outstanding 5160.55M
Float 118.65M
% Held by Insiders 120.70%
% Held by Institutions 10.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/11
Last Split Date 3May 28, 2013